Aerie Pharmaceuticals

Aerie Pharmaceuticals is a clinical stage pharmaceutical company developing first in class glaucoma therapies including Rhopressa™ and Roclatan™. The company required funding in order to complete the registration trials needed for FDA approval and to prepare for commercial launch activities.